Avalo Therapeutics Inc Free Cash Flow Generation Index

Latest as of September 2022: 0.99x

Avalo Therapeutics Inc free cash flow generation index. Avalo Therapeutics Inc (AVTX) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $5.69 Million represents 1% of operating cash flow ($5.73 Million).

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$5.69 Million
USD

Operating Cash Flow

$5.73 Million
USD

Capital Expenditures

$39.00K
USD

Free Cash Flow Generation Index of Avalo Therapeutics Inc (2017–2017)

Free cash flow generation index of Avalo Therapeutics Inc from 2017 to 2017. Historical FCF Generation Index trend for Avalo Therapeutics Inc across 1 annual periods. See Avalo Therapeutics Inc (AVTX) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Avalo Therapeutics Inc Free Cash Flow Generation Index by Year (2017–2017)

Avalo Therapeutics Inc free cash flow generation index by year from 2017 to 2017. Year-by-year Free Cash Flow Generation Index for Avalo Therapeutics Inc. For the full cash flow conversion analysis, see Avalo Therapeutics Inc operating cash flow efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2017 1.00x $12.50 Million $12.52 Million $23.32K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).